May 16 Arena Pharmaceuticals Inc:
* Arena Pharmaceuticals to present Phase 1 data on Ralinepag for treatment of Pulmonary Arterial Hypertension at the American Thoracic Society 2017 International Conference Source text for Eikon: Further company coverage:
WORLD NEWS SCHEDULE AT 1800 GMT/2 PM ET
Iraqi forces free hundreds of civilians in Mosul Old City battles as death toll mounts
CEO of Raytheon's Forcepoint eyes IPO -Boersen-Zeitung
FRANKFURT, June 24 U.S. missile maker Raytheon's cybersecurity unit could thrive were it to be listed separately, the head of the unit, Forcepoint, told German business daily Boersenzeitung in an interview published on Saturday.